Biosurgery-EMEA Market Status and Trend Report 2013-2023
Report Summary
Biosurgery-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosurgery industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Biosurgery 2013-2017, and development forecast 2018-2023
Main market players of Biosurgery in EMEA, with company and product introduction, position in the Biosurgery market
Market status and development trend of Biosurgery by types and applications
Cost and profit status of Biosurgery, and marketing status
Market growth drivers and challenges
The report segments the EMEA Biosurgery market as:
EMEA Biosurgery Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Biosurgery Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical Sealants
Hemostatic Agents
Adhesion Barriers
Bone Graft Substitutes
Staple Line Reinforcement Agents
EMEA Biosurgery Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Neurological Surgeries
Cardiovascular Surgeries
General Surgeries
Orthopedic Surgeries
Thoracic Surgeries
Gynecology Surgeries
Urology Surgeries
Reconstructive Surgeries
EMEA Biosurgery Market: Players Segment Analysis (Company and Product introduction, Biosurgery Sales Volume, Revenue, Price and Gross Margin):
Baxter International
C.R. Bard
Johnson & Johnson
Covidien
Getinge Group
B. Braun Melsungen AG
Cryolife
Stryker Corporation
Hemostasis
Sanofi
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biosurgery-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosurgery industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Biosurgery 2013-2017, and development forecast 2018-2023
Main market players of Biosurgery in EMEA, with company and product introduction, position in the Biosurgery market
Market status and development trend of Biosurgery by types and applications
Cost and profit status of Biosurgery, and marketing status
Market growth drivers and challenges
The report segments the EMEA Biosurgery market as:
EMEA Biosurgery Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Biosurgery Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical Sealants
Hemostatic Agents
Adhesion Barriers
Bone Graft Substitutes
Staple Line Reinforcement Agents
EMEA Biosurgery Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Neurological Surgeries
Cardiovascular Surgeries
General Surgeries
Orthopedic Surgeries
Thoracic Surgeries
Gynecology Surgeries
Urology Surgeries
Reconstructive Surgeries
EMEA Biosurgery Market: Players Segment Analysis (Company and Product introduction, Biosurgery Sales Volume, Revenue, Price and Gross Margin):
Baxter International
C.R. Bard
Johnson & Johnson
Covidien
Getinge Group
B. Braun Melsungen AG
Cryolife
Stryker Corporation
Hemostasis
Sanofi
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOSURGERY
1.1 Definition of Biosurgery in This Report
1.2 Commercial Types of Biosurgery
1.2.1 Surgical Sealants
1.2.2 Hemostatic Agents
1.2.3 Adhesion Barriers
1.2.4 Bone Graft Substitutes
1.2.5 Staple Line Reinforcement Agents
1.3 Downstream Application of Biosurgery
1.3.1 Neurological Surgeries
1.3.2 Cardiovascular Surgeries
1.3.3 General Surgeries
1.3.4 Orthopedic Surgeries
1.3.5 Thoracic Surgeries
1.3.6 Gynecology Surgeries
1.3.7 Urology Surgeries
1.3.8 Reconstructive Surgeries
1.4 Development History of Biosurgery
1.5 Market Status and Trend of Biosurgery 2013-2023
1.5.1 EMEA Biosurgery Market Status and Trend 2013-2023
1.5.2 Regional Biosurgery Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biosurgery in EMEA 2013-2017
2.2 Consumption Market of Biosurgery in EMEA by Regions
2.2.1 Consumption Volume of Biosurgery in EMEA by Regions
2.2.2 Revenue of Biosurgery in EMEA by Regions
2.3 Market Analysis of Biosurgery in EMEA by Regions
2.3.1 Market Analysis of Biosurgery in Europe 2013-2017
2.3.2 Market Analysis of Biosurgery in Middle East 2013-2017
2.3.3 Market Analysis of Biosurgery in Africa 2013-2017
2.4 Market Development Forecast of Biosurgery in EMEA 2018-2023
2.4.1 Market Development Forecast of Biosurgery in EMEA 2018-2023
2.4.2 Market Development Forecast of Biosurgery by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Biosurgery in EMEA by Types
3.1.2 Revenue of Biosurgery in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Biosurgery in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biosurgery in EMEA by Downstream Industry
4.2 Demand Volume of Biosurgery by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biosurgery by Downstream Industry in Europe
4.2.2 Demand Volume of Biosurgery by Downstream Industry in Middle East
4.2.3 Demand Volume of Biosurgery by Downstream Industry in Africa
4.3 Market Forecast of Biosurgery in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOSURGERY
5.1 EMEA Economy Situation and Trend Overview
5.2 Biosurgery Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOSURGERY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Biosurgery in EMEA by Major Players
6.2 Revenue of Biosurgery in EMEA by Major Players
6.3 Basic Information of Biosurgery by Major Players
6.3.1 Headquarters Location and Established Time of Biosurgery Major Players
6.3.2 Employees and Revenue Level of Biosurgery Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOSURGERY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Baxter International
7.1.1 Company profile
7.1.2 Representative Biosurgery Product
7.1.3 Biosurgery Sales, Revenue, Price and Gross Margin of Baxter International
7.2 C.R. Bard
7.2.1 Company profile
7.2.2 Representative Biosurgery Product
7.2.3 Biosurgery Sales, Revenue, Price and Gross Margin of C.R. Bard
7.3 Johnson & Johnson
7.3.1 Company profile
7.3.2 Representative Biosurgery Product
7.3.3 Biosurgery Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.4 Covidien
7.4.1 Company profile
7.4.2 Representative Biosurgery Product
7.4.3 Biosurgery Sales, Revenue, Price and Gross Margin of Covidien
7.5 Getinge Group
7.5.1 Company profile
7.5.2 Representative Biosurgery Product
7.5.3 Biosurgery Sales, Revenue, Price and Gross Margin of Getinge Group
7.6 B. Braun Melsungen AG
7.6.1 Company profile
7.6.2 Representative Biosurgery Product
7.6.3 Biosurgery Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG
7.7 Cryolife
7.7.1 Company profile
7.7.2 Representative Biosurgery Product
7.7.3 Biosurgery Sales, Revenue, Price and Gross Margin of Cryolife
7.8 Stryker Corporation
7.8.1 Company profile
7.8.2 Representative Biosurgery Product
7.8.3 Biosurgery Sales, Revenue, Price and Gross Margin of Stryker Corporation
7.9 Hemostasis
7.9.1 Company profile
7.9.2 Representative Biosurgery Product
7.9.3 Biosurgery Sales, Revenue, Price and Gross Margin of Hemostasis
7.10 Sanofi
7.10.1 Company profile
7.10.2 Representative Biosurgery Product
7.10.3 Biosurgery Sales, Revenue, Price and Gross Margin of Sanofi
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOSURGERY
8.1 Industry Chain of Biosurgery
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOSURGERY
9.1 Cost Structure Analysis of Biosurgery
9.2 Raw Materials Cost Analysis of Biosurgery
9.3 Labor Cost Analysis of Biosurgery
9.4 Manufacturing Expenses Analysis of Biosurgery
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOSURGERY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Biosurgery in This Report
1.2 Commercial Types of Biosurgery
1.2.1 Surgical Sealants
1.2.2 Hemostatic Agents
1.2.3 Adhesion Barriers
1.2.4 Bone Graft Substitutes
1.2.5 Staple Line Reinforcement Agents
1.3 Downstream Application of Biosurgery
1.3.1 Neurological Surgeries
1.3.2 Cardiovascular Surgeries
1.3.3 General Surgeries
1.3.4 Orthopedic Surgeries
1.3.5 Thoracic Surgeries
1.3.6 Gynecology Surgeries
1.3.7 Urology Surgeries
1.3.8 Reconstructive Surgeries
1.4 Development History of Biosurgery
1.5 Market Status and Trend of Biosurgery 2013-2023
1.5.1 EMEA Biosurgery Market Status and Trend 2013-2023
1.5.2 Regional Biosurgery Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biosurgery in EMEA 2013-2017
2.2 Consumption Market of Biosurgery in EMEA by Regions
2.2.1 Consumption Volume of Biosurgery in EMEA by Regions
2.2.2 Revenue of Biosurgery in EMEA by Regions
2.3 Market Analysis of Biosurgery in EMEA by Regions
2.3.1 Market Analysis of Biosurgery in Europe 2013-2017
2.3.2 Market Analysis of Biosurgery in Middle East 2013-2017
2.3.3 Market Analysis of Biosurgery in Africa 2013-2017
2.4 Market Development Forecast of Biosurgery in EMEA 2018-2023
2.4.1 Market Development Forecast of Biosurgery in EMEA 2018-2023
2.4.2 Market Development Forecast of Biosurgery by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Biosurgery in EMEA by Types
3.1.2 Revenue of Biosurgery in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Biosurgery in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biosurgery in EMEA by Downstream Industry
4.2 Demand Volume of Biosurgery by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biosurgery by Downstream Industry in Europe
4.2.2 Demand Volume of Biosurgery by Downstream Industry in Middle East
4.2.3 Demand Volume of Biosurgery by Downstream Industry in Africa
4.3 Market Forecast of Biosurgery in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOSURGERY
5.1 EMEA Economy Situation and Trend Overview
5.2 Biosurgery Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOSURGERY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Biosurgery in EMEA by Major Players
6.2 Revenue of Biosurgery in EMEA by Major Players
6.3 Basic Information of Biosurgery by Major Players
6.3.1 Headquarters Location and Established Time of Biosurgery Major Players
6.3.2 Employees and Revenue Level of Biosurgery Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOSURGERY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Baxter International
7.1.1 Company profile
7.1.2 Representative Biosurgery Product
7.1.3 Biosurgery Sales, Revenue, Price and Gross Margin of Baxter International
7.2 C.R. Bard
7.2.1 Company profile
7.2.2 Representative Biosurgery Product
7.2.3 Biosurgery Sales, Revenue, Price and Gross Margin of C.R. Bard
7.3 Johnson & Johnson
7.3.1 Company profile
7.3.2 Representative Biosurgery Product
7.3.3 Biosurgery Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.4 Covidien
7.4.1 Company profile
7.4.2 Representative Biosurgery Product
7.4.3 Biosurgery Sales, Revenue, Price and Gross Margin of Covidien
7.5 Getinge Group
7.5.1 Company profile
7.5.2 Representative Biosurgery Product
7.5.3 Biosurgery Sales, Revenue, Price and Gross Margin of Getinge Group
7.6 B. Braun Melsungen AG
7.6.1 Company profile
7.6.2 Representative Biosurgery Product
7.6.3 Biosurgery Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG
7.7 Cryolife
7.7.1 Company profile
7.7.2 Representative Biosurgery Product
7.7.3 Biosurgery Sales, Revenue, Price and Gross Margin of Cryolife
7.8 Stryker Corporation
7.8.1 Company profile
7.8.2 Representative Biosurgery Product
7.8.3 Biosurgery Sales, Revenue, Price and Gross Margin of Stryker Corporation
7.9 Hemostasis
7.9.1 Company profile
7.9.2 Representative Biosurgery Product
7.9.3 Biosurgery Sales, Revenue, Price and Gross Margin of Hemostasis
7.10 Sanofi
7.10.1 Company profile
7.10.2 Representative Biosurgery Product
7.10.3 Biosurgery Sales, Revenue, Price and Gross Margin of Sanofi
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOSURGERY
8.1 Industry Chain of Biosurgery
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOSURGERY
9.1 Cost Structure Analysis of Biosurgery
9.2 Raw Materials Cost Analysis of Biosurgery
9.3 Labor Cost Analysis of Biosurgery
9.4 Manufacturing Expenses Analysis of Biosurgery
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOSURGERY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
